LUNGevity Foundation Receives Lung Cancer Advocacy Award

Award Recognizes LUNGevity for its Outstanding Research and Patient Education

FOR IMMEDIATE RELEASE

Media Contact:
Victoria Shapiro
(202) 414-0774
vshapiro@susandavis.com
 

WASHINGTON (October 17, 2011) – LUNGevity Foundation is the recipient of the University of Pennsylvania’s Abramson Cancer Center Lung Cancer Advocacy Award in recognition of their Outstanding Research and Patient Education.  The foundation was also recognized for the tremendous support and community that they offer for the thousands of people affected by lung cancer annually. Each year, the Abramson Cancer Center selects a lung cancer organization to receive the award based on their contributions to lung cancer support and advocacy.  The award was presented at Abramson’s Focus on Lung Cancer Conference in Philadelphia, PA on October 14, 2011. 

“I am honored to accept this award on behalf of LUNGevity Foundation and would like to recognize all of the volunteers and constituents who help us accomplish our mission every day,” said Andrea Stern Ferris, president of LUNGevity Foundation. “We are proud that we are able to create a community for all people affected by lung cancer and provide essential support to those in need in addition to funding critical research.  We are grateful to the Abramson Cancer Center and applaud them for the impactful translational lung cancer research that they conduct.” 

Lung cancer impacts 1 in 14 Americans over their lifetimes and kills over 400 people every day.  LUNGevity is committed to changing that statistic and providing hope for the 200,000 people diagnosed every year with lung cancer.

About LUNGevity Foundation

The mission of LUNGevity Foundation is to have a meaningful and immediate impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.

In order to accomplish our mission, LUNGevity funds the most promising research into the early detection and successful treatment of lung cancer. LUNGevity also supports the largest national grassroots lung cancer network, as well as the largest online support community for those affected by lung cancer.

The organization was recently awarded the coveted four-star charity ranking by Charity Navigator, American’s premier charity evaluator based on LUNGevity’s sound fiscal management and commitment to accountability and transparency.

LUNGevity seeks to inspire the nation to commit to ending lung cancer. 

For more information, please visit www.lungevity.org.

About Lung Cancer

  • Lung cancer is the leading cause of cancer death, regardless of gender or ethnicity.
  • Lung cancer impacts one in 14 Americans and kills more than breast, prostate, colorectal, leukemia, and melanoma cancers combined.
  • Lung cancer kills almost twice as many women as breast cancer, and more than twice as many men as prostate cancer.
  • About 55% of all new lung cancer diagnoses are among people who have never smoked or are former smokers.
  • Lung cancer accounts for 14% of all new cancer diagnoses but 27% of all cancer deaths.